Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.

By Peter M. Rothwell, S. Howard, E. Dolan, E. O’Brien, J. Dobson, B. Dahlöf, P. Sever, N. Poulter. The Lancet, 2010

1,659 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/861ddfec216067a2bc69e5e1a11865655aebfa05

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. I. Wilkinson
2. Philippe van de Borne
3. C. Bushnell
4. J. Cockcroft
5. E. Schiffrin
6. C. Iadecola
7. Gary F. Mitchell
8. E. Lakatta

In Epidemiology

1. Philippe van de Borne
2. Mitchell S. V. Elkind
3. C. Iadecola
4. R. Eckel
5. K. Jellinger

In Surgery

1. Philippe van de Borne
2. C. Bushnell
3. R. Eckel
4. M. Creager

Citations in the corpus

• The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “predominant BP values [435].”
• Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness (2015, positive): “In addition, increased aortic stiffness is associated with BP lability, which is a risk factor for incident stroke.(102)”
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (2019, background): “antihypertensive drugs other than CCBs increased the visitto-visit variability [192], that CCBs and ARB reduced the visit-to-visit variability [354] and that the visit-to-visit”
• Stroke Risk Factors, Genetics, and Prevention (2017, background): “trials of patients with hypertension, previous stroke, or previous transient ischemic attack, found that variability in 2 to 10 blood pressure measures over ≈2 years is a risk factor for stroke, independent of mean blood pressure.(71) The measure of blood pressure variability may serve as an indicat”
• ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “7 Antihypertensive agents and visit-to-visit blood pressure variability Attention has recently been drawn to the association of visit-to-visit variability of intra-individual BP during antihypertensive treatment and the incidence of CV events (particularly stroke) in high-risk patients.(435) In coro”
• Guidelines for the Primary Prevention of Stroke (2011, positive): “Recent evidence suggests that intraindividual variability in BP may confer risk beyond that caused by mean elevations in BP alone.(252) There is further observational evidence that calcium channel blockers may have benefits in reducing BP variability that are not present with β-blockers and that the”